Literature DB >> 21107204

Relationship of angiogenic potential with clinical features in cranial meningiomas: a corneal angiogenesis study.

Zafer Orkun Toktas1, Emel Akgun, Abdulkadir Ozkan, Suheyla Uyar Bozkurt, Nural Bekiroglu, Askin Seker, Deniz Konya, Turker Kilic.   

Abstract

BACKGROUND: Intracranial meningiomas constitute approximately one fourth of all primary intracranial tumors. The invention of cranial angiographic techniques has led to the recognition of the angiogenic potential of meningiomas, which has been the subject of extensive research.
OBJECTIVE: To test the relationship between the angiogenetic potential of intracranial meningiomas and clinical/prognostic features such as World Health Organization (WHO) grade, peritumoral edema, tumor border shape, and recurrence using rat corneal angiogenesis assay.
METHODS: Fifteen WHO grade I (typical), 10 WHO grade II (atypical), and 5 WHO grade III (malignant) meningioma samples were implanted in the micropockets formed on rat corneas, and the number of developed vessels were counted on days 5, 10, 15, and 20. Normal brain and glioblastoma multiforme tissues served as negative and positive controls, respectively. Patients were evaluated by magnetic resonance imaging preoperatively and every 6 months thereafter.
RESULTS: The angiogenic potential of WHO grade II tumors was significantly lower than that of grade III tumors and higher than that of grade I tumors throughout the experiment. Tumors with a smooth border shape and nonrecurrent tumors exhibited significantly lower angiogenic activity compared with the tumors with irregular border shape and recurrent tumors, respectively. No association was found between angiogenic activity and peritumoral edema. However, multivariate analysis identified WHO grade, recurrence, and peritumoral edema as significant predictors of a high angiogenic potential.
CONCLUSION: Our findings, based on a dynamic in vivo model to examine angiogenesis, demonstrate that the angiogenic potential of meningiomas is correlated with WHO grade, recurrence, and possibly with tumor border shape and peritumoral edema. Angiogenesis seems to be an important factor in the natural course of meningiomas, suggesting that inhibition of angiogenesis may be an option, particularly in the treatment of meningiomas with an aggressive course.

Entities:  

Mesh:

Year:  2010        PMID: 21107204     DOI: 10.1227/NEU.0b013e3181f9f310

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis.

Authors:  Oksan Karal-Yilmaz; Abdulkadir Ozkan; Emel Akgun; Manolya Kukut; Kemal Baysal; Timucin Avsar; Turker Kilic
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

2.  Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study.

Authors:  Eman Abdelzaher; Dina Mohamed Abdallah
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.